<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This study reviewed the immunophenotyping results of children with <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> in Kelantan, Malaysia </plain></SENT>
<SENT sid="1" pm="."><plain>In the 3.5-year period (January 1994 to June 1997), 45 cases were identified </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> children were under the age of 12 years and the predominant ethnic group was Malay </plain></SENT>
<SENT sid="3" pm="."><plain>Thirty-six cases (80%) were <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (ALL) and 9 cases (20%) were <z:hpo ids='HP_0004808'>acute myeloblastic leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) </plain></SENT>
<SENT sid="4" pm="."><plain>Of the ALL cases, 3% were of B-cell and 22% of T-cell origin, and 96% of the B-lineage ALL were CD10 positive </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> cases expressed CD33 and 78% were positive for CD13 </plain></SENT>
<SENT sid="6" pm="."><plain>The incidence of mixed-lineage <z:hpo ids='HP_0001909'>leukemias</z:hpo> was 13.8% for My+ ALL and 11.1% for Ly+ <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
</text></document>